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REVIEW

Increasing Actual and Perceived Burden of Tick-Borne
Disease in Maine
Robert P. Smith MD, MPH,1 Carol A. McCarthy MD2, Susan P. Elias PhD1
Vector-borne Disease Research Laboratory, Maine Medical Center Research Institute, Scarborough, ME, 2Department of
Pediatrics, Maine Medical Center, Portland, ME
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Introduction:

The burden of tick-borne diseases (TBDs) in Maine has steadily increased since the first case of
Lyme disease was reported in the late 1980s. Five different agents of TBDs have emerged in Maine,
challenging clinicians and the public .

Methods:

We reviewed the ecology of emerging TBDs as well as the risk factors for tick bites and TBDs in Maine.
We then evaluated the burden of TBDs versus comparable community-acquired infections in terms of
hospitalizations, deaths, and media attention.

Results:

In Maine, the risk of exposure to bites from the vector blacklegged or “deer tick”, Ixodes scapularis, is a
reality in most of the state. In New England, the deer tick’s range has expanded from relict populations
in southern New England northward due to reforestation, resurgence of white-tailed deer (Odocoileus
virginianus), suburbanization, and climate change. In Maine, TBDs have emerged as a significant
health burden, but they receive disproportionately high media attention compared with other infections
important to public health. Measures of TBD severity provide a necessary context for individual and
public health decision-making. Mass media reports and social networking inform much public debate
regarding TBDs, but in many instances, they do not accurately reflect their actual prevalence or expected
outcome.

Conclusions:

Reducing actual and perceived risks associated with TBDs will require well-supported information and
an appreciation for how interpersonal communication and social media drive community perceptions
and responses to the emergence of TBDs.
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S

ince the first reports of Lyme disease in
Maine in 1986, tick-borne diseases (TBDs)
have assumed an increasingly high profile
in the state’s public health reports1 and in public
attention. The deer (blacklegged) tick (Ixodes
scapularis), now widespread across Maine, carries
up to five different human pathogens. The recent
emergence of this tick and the diseases it can
transmit represent a remarkable occurrence in the
regional annals of infectious diseases.2
Case reports of Lyme disease rose from a few per
year in the late 1980s to more than a thousand per
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year during the past five years. These reports are
likely a significant underestimate of actual cases.
Geographic risk increased from a few southern and
coastal counties to nearly all areas of the state.1,3
Anaplasmosis and babesiosis cause serious
infection in the elderly or immune suppressed,4 and
cases of both infections increased sharply from 2013
to 2017 [605% (94 to 663) for anaplasmosis and
69% (36 to 118) for babesiosis].1 These ticks also
can transmit a virus (Powassan virus or “deer-tick
virus”) that can cause a devastating encephalitis, an
effect underscored by the death of a Maine resident
from this agent in 2013.5 To add to the complexity,
another species of Borrelia (B. miyamotoi), which
differs in some aspects from B. burgdorferi, causes
a febrile illness similar to anaplasmosis. If untreated,
it can occasionally cause relapses of fever.6 The full
1

Journal of Maine Medical Center, Vol. 1 [2019], Iss. 1, Art. 13

spectrum of disease caused by Powassan virus
and Borrelia miyamotoi is still under study.
This article first reviews what we know about the
ecology of emerging of TBDs. Then it reviews risk
factors for tick bites and TBD in Maine. We discuss
this phenomenon in the broader context of publichealth threats in Maine through data we gathered
on hospitalizations and deaths attributable to TBDs,
which we compared to conditions such as influenza.
We also assessed the volume of news coverage
of TBDs versus comparison conditions. In doing
so, we revealed a disconnect between standard
measures of the burden of TBD versus the burden
implied by the frequency of media coverage. We
also addressed causes and consequences of
public misperceptions of disease prevalence and
outcome.
Review: Ecology of emerging TBD in Maine
Progressive expansion of deer ticks across the
northeastern United States and the upper Midwest
reflects widespread ecologic changes.7,8 The rising
incidence of human TBD is due to the geographic
range expansion of deer ticks and increased
human encounters with ticks in residential areas.3,8,9
However, enhanced clinical recognition and
availability of improved diagnostic tests may also
contribute to the increase in case reports.
In the late 1980s, deer ticks appeared in Maine in
a discontinuous distribution that included sites in
southern coastal York and Cumberland Counties,
as well as Acadia National Park and remote islands,
such as Monhegan Island.3,10,11,12 This patchy pattern
of initial colonization of Maine by Ixodes scapularis
is best explained by passerine birds that introduce
the tick while they migrate during the spring, as
shown by studies on migrating birds banded on
Appledore Island.13 Once dispersed by birds, larval
and nymphal ticks feed upon small rodents, and to
a lesser extent, larger mammals and birds. Adult
ticks feed on large mammal hosts, particularly
white-tailed deer. White-tailed deer are the key
large mammal involved in the tick’s life cycle, as a
large number of ticks feed and mate on them.14
Why the relatively recent dispersal of deer ticks by
migrating birds? The most compelling explanation
is the increase in white-tailed deer abundance in
the northeast United States. Deer ticks were once
isolated to relict populations in southern New
England. They have expanded geographically
https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/13
DOI: 10.46804/2641-2225.1016

during the 20th and 21st century, due to resurgence
of white-tailed deer populations, reforestation, and
suburbanization of the landscape.7,15 Abundant
deer support focal concentrations of deer ticks as
they are dispersed by migratory birds from endemic
areas to new ones.
In the early 1900s, deer populations were sparse
in much of Maine, gradually increasing over the
following decades. Through the late-1980s and
1990s, Maine’s deer population increased 65%,
rising from ~200,000 deer in 1990 to a high of
331,000 in 1999.16 This occurred mainly in the
central and southern tiers of the state, increasing
the odds that tick populations would establish in
regions where most of the human population lives.
Tick abundance is correlated with measures of
deer abundance in Maine.17 Removal of deer from
Monhegan Island with subsequent disruption of the
deer tick life cycle there provided a proof of principle
of the white-tailed deer’s critical role.17,18
In addition to an increased number of deer, a
warming climate confers survival advantages to deer
ticks in northern areas of Maine and adjacent areas
of Canada.19,20 Climate change is also facilitating
the movement of other tick vectors northward, with
reports of Ambylomma americanum, the lone star
tick, now established in areas of southern New
England.
Review: Risk factors for deer-tick bites and TBD
in Maine
In the northeastern US, exposure to deer-tick bites
occurs primarily in the peri-domestic environment
(i.e., yards and other areas around residences).9
This exposure is a product of the time spent in
activities outside on home properties, and the
presence of suitable habitat and tick hosts, such
as rodents and deer, next to households.9,15,21 In
Maine, Lyme disease incidence varies from lower
in the northern tier to higher in the southern tier of
the state (Table 1) likely due to variations in suitable
climate, bloodmeal-host communities, and habitats.
In addition to the peri-domestic environment, human
risk of infection varies with outdoor recreational or
work activities.9 Though early studies demonstrated
focal risk in the southern and mid-coast counties,
exposure to deer ticks now occurs in all areas
of Maine, with the exception of higher montane
elevations.3, Within counties, there are areas of high
risk and areas of low or negligible risk. In open fields
2
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Table 1. Five-year average incidence (cases per
100,000) of the three most common tick-borne diseases
vectored by Ixodes scapularis in Maine (2013–2017)*.
Anaplasmosis

Babesiosis

Lyme
disease

Maine

22.6

5.0

110.5

Androscoggin

14.3

2.8

75.8

Aroostook

0.6

0.0

5.5

Cumberland

17.0

4.6

109.0

Franklin

3.3

0.0

38.5

Hancock

17.6

1.5

256.0

Kennebec

20.2

3.3

156.0

Knox

138.0

31.7

287.6

Lincoln

133.0

17.0

236.1

Oxford

9.8

2.4

76.9

Penobscot

1.4

0.9

46.4

Piscataquis

2.4

1.2

15.3

Sagadahoc

67.1

11.4

184.3

Somerset

3.1

1.6

75.1

Waldo

29.6

1.5

211.4

Washington

1.3

0.0

63.1

York

27.5

9.2

105.3

State/County

*There have been six cases of hard-tick relapsing fever
caused by Borrelia miyamotoi: 2016-2, 2017-6; and six
cases of Powassan encephalitis: 2013-1, 2015-1, 20161, 2017-31

and drier habitats, bites by other tick species, such
as dog ticks (Dermacentor variabilis) that do not
carry diseases in Maine, are more likely. Of 12 tick
species removed from humans in Maine, dog ticks
are the second-most common human-biting tick
after deer ticks.3 Habitat studies have shown deer
ticks are less associated with fields and softwood
(coniferous) forests and more associated with
hardwood and mixed hardwood/softwood forests.
They are especially associated with dense thickets
of invasive plants, such as Japanese barberry or
American bittersweet.22 Higher rates of tick contact
near homes also occur at lawn edges bordered by
brush or forest.21
Reported cases of Lyme disease in Maine have
a bimodal age distribution, indicating highest risk
in youth (ages 5 to 14) and adults over age 45.1
However, susceptibility to clinical illness from Lyme
disease does not vary with age, whereas diseases
such as anaplasmosis and babesiosis occur more
often and with greater severity with older age. Illness
due to anaplasmosis or babesiosis is uncommon in
the pediatric population.1 While Lyme disease and
Published by MaineHealth Knowledge Connection, 2019

anaplasmosis may be acquired by deer tick bites
anywhere the tick occurs in Maine, babesiosis risk
is more geographically limited, with human cases
largely confined to areas with the highest risk of
Lyme disease.4 Asplenia, immune compromise,
and age are risk factors for severe babesiosis.23
Rarer agents of disease, such as B. miyamotoi and
Powassan virus, only infect a few percent of Maine
ticks but are present in deer ticks in most locations
studied (Maine Medical Center Research Institute
Vector Borne Disease Laboratory; unpublished
data).
The ubiquitous presence of ticks in many peridomestic environments results in a high frequency
of tick encounters and bites in the community,
heightening concerns about the risk of illness.9,15
Syndromic surveillance in Maine, based on
documentation of visits to Maine urgent care
centers and ERs,24 show peaks of over 100 “tick
encounters” per day during peak weeks in early
summer (nymphs) and mid-fall (adults). The
Centers for Disease Control (CDC) reported that
in suburban residences of southern New England,
nearly 10% of individuals studied reported peridomestic tick contact during one summer week
of high tick activity.9 Similar numbers may apply
to higher risk residential areas in Maine. The high
frequency of tick encounters leads to appropriate
public concerns regarding the consequences of
tick bites. However, subjective perceptions of the
inherent risk of infection from a deer tick bite are
often overestimated, as are the expected negative
health consequences of TBDs.25–27
If a deer tick bite occurs, the objective risk of
illness varies with the infectious agent, the time of
tick attachment, subject age, immune status, and
geography.15 Well-designed studies demonstrate
that transmission of Lyme disease usually requires
continuous tick attachment for more than 36–48
hours.28,29 As many ticks are removed early in
their feeding, the objective risk of acquiring Lyme
disease after removing an attached deer tick within
72 hours is less than 5%, even though up to 50% of
nymphal deer ticks carry B. burgdorferi.15,28–30 Adult
ticks are discovered and removed prior to 36 hours
of attachment (64%) more often than the much
smaller nymphs (40%).15,31 Data are less robust for
other agents. However, most disease transmission
requires 24 hours of attachment, with the significant
exception that Powassan virus may be transmitted
in only 15 minutes of tick attachment.30 Ticks
3
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feeding to repletion over a longer interval steadily
increases the risk of disease transmission.28 Most
cases of Lyme disease occur without a reported
tick bite, indicating that the infecting tick is often not
found before it finishes feeding.15 While co-infection
of deer ticks with more than one pathogen has been
documented in 0–5% of Maine ticks (depending on
the location; unpublished data), the vast majority
of reported cases of TBD are due to infection by a
single agent.
Actual and perceived burden of TBD in Maine
Hospitalization data were obtained from the
Maine Health Data Organization using ICD9 and
ICD10 codes. For the chronic conditions hepatitis
B, hepatitis C, and HIV, hospitalizations were
counted on the basis of primary diagnosis. For the
acute TBDs and influenza, hospitalizations were
counted on the basis of either primary diagnosis
or other diagnosis 1 through 8. For endocarditis
with drug use, we counted hospitalizations
using the codes described by Fleischauer et al.32
Sources for mortality data included TBD deaths
in Maine residents (Robinson S, M.P.H., personal
communication, January 8, 2019) and Maine
Resident Deaths33 for non-vector-borne deaths.
Deaths from endocarditis with drug use were not
available from Maine Resident Deaths, so these
deaths were estimated as 19% of hospitalizations
(Table 2) based on recent findings.34 Finally, we
conducted a Lexis Uni® database search of media

coverage, specifying coverage between January 1,
2014 and December 31, 2018, the word “Maine”,
and the infectious disease conditions described in
Table 2.
There were fewer hospitalizations (23.3%)
and deaths (0.2%) attributable to TBDs than
hospitalizations (76.7%) and deaths (99.8%) due to
the other infections examined (Table 2). In contrast,
the Lexis Uni® database search of media coverage
revealed that 41.4% of news coverage focused on
Lyme disease and other TBDs compared to 58.6%
for the other infectious diseases that threaten public
health.
Combined hospital admissions for TBDs may rival
some other individual reportable infections (Table
2), but with far fewer fatalities. Fatalities from Lyme
disease have been reported in a small number of
patients with Lyme carditis nationwide.35 These
fatalities are exceedingly rare36 and are quite
infrequent with anaplasmosis or babesiosis, despite
potentially severe disease in the elderly and immune
suppressed.23 Other community-acquired infections
leading to hospitalization more significantly burden
public health when measured by mortality (Table 2).
Notably, the collateral effects of infections related to
the opioid epidemic (i.e., infections associated with
use of injected drugs, including hepatitis C, bacterial
endocarditis, and osteomyelitis) have rapidly risen
in prevalence.

Table 2. Frequency of hospitalizations for and deaths from tick-borne diseases and select non-vector-borne
diseases or conditions (2013–2017), and frequency of news articles that mentioned Maine and the selected
diseases or conditions (January 1, 2014–December 31, 2018).
Hospitalizations
Deaths
News Articles
Disease or Condition
Count
% of Total
Count % of Total
Count % of Total
Tick-borne
Anaplasmosis
419
12.3
2
0.1
47
2.9
Babesiosis
116
3.4
3
0.1
34
2.1
Borrelia miyamoti disease
unknown
0
0.0
6
0.4
Lyme disease*
261
7.6
0
0.0
555
34.0
Powassan
unknown
1
0.0
33
2.0
Total tick-borne
796
23.3
6
0.2
675
41.4
Non-vector-borne
Hepatitis B,C
344
10.1
223
7.6
174
10.7
HIVe
278
8.1
96
3.3
481
29.5
Influenza
1998
58.5
2599
88.9
299
18.3
Endocarditis with drug use
593
17.4
113
3.9
1
0.1
Total Non-vector-borne
2620
76.7
2918
99.8
954
58.5
Total
3416
2924
1629
*Lyme hospitalizations included 227 of Lyme, Lyme arthritis, and Lyme meningitis, plus 34 of Lyme carditis
https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/13
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Repetitive coverage of any particular infectious
disease by the mass media heightens the public’s
perceptions of disease risk and severity.25 This effect
can stimulate further media attention in an amplified
cycle that increases the public’s perceptions of risk
even more.37 In addition, the content of mass media
reports on Lyme disease often highlights individual
narratives of unusually long or debilitating illness
attributed to chronic infection.25 These reports are
frequently re-enforced by interpersonal information
from social networks.26 A survey of residents in two
endemic sites in southern New England noted that
inaccurate views of the expected clinical outcomes
of Lyme disease were based upon shared
personal narratives rather than information from
physicians, the CDC, or state health departments.26
Anecdotal reports amplified by social media may
result in “information silos” that not only increase
the prevalence of unchallenged misinformation,
but also appear to fuel distrust of information
provided by public health and medical experts.38-41
Nationally, prevalence of public misconceptions
regarding current scientific evidence contributes to
incomplete use of proven preventive measures.27,40
They also contribute to overuse of antibiotic and
unproven treatment strategies, including long-term
polypharmacy for putative multiple co-infections.42-46
The emergence of TBDs in Maine over the past
3 decades represents a substantial challenge in
public health. Yet the concomitant perpetuation
of disparate beliefs regarding the risks of TBDs
complicates both individual decisions regarding
treatment and the public health response.26, 38-40,44-47
There are no published Maine-based surveys that
document the current prevalence and the range
of knowledge and beliefs regarding the risks and
consequences of TBDs. However, the public’s
high concern is reflected by advocacy for Maine
legislative initiatives (i.e., three bills specific to Lyme
disease signed between 2013 and 2018), media
attention (Table 2), and Maine CDC investment in
public educational initiatives as outlined in annual
reports to the Maine Legislature.24
A limitation to our analysis was an inability to assess
chronic disability. With low mortality rates from TBDs,
specific measures, such as years of life lost (YLL),
will also be relatively low. The years of “healthy life
lost”, or disability-adjusted life years (DALYS), is a
more challenging measurement.48 Comprehensive
YLL and DALYS data for TBDs are not available.
Although long-term prospective outcome studies of
Published by MaineHealth Knowledge Connection, 2019

Lyme disease do not demonstrate differences from
the health of the general population,49,50 individuals
may experience persisting complications. For
example, a small subset of patients treated
for Lyme arthritis develop a disabling form of
autoimmune mono-articular joint inflammation.
Neurologic disease (primarily 7th nerve palsy and/
or Lyme meningitis) was reported in up to 10% of
newly diagnosed cases of Lyme disease1 and is
generally slow to resolve after antibiotic treatment.
Long-term residual neurologic symptoms are
rarely reported. Continuing controversy regarding
disease outcomes centers on estimates of the
incidence and duration of subjective illness
(e.g., fatigue, arthralgias, cognitive symptoms)
following antibiotic treatment of documented Lyme
disease.44,51,52 Similar controversies now extend to
the full spectrum of possible “co-infecting” TBDs
and, surprisingly, even to a group of infectious
agents not demonstrated to be transmitted by deer
ticks (e.g., Bartonella species).42
The causes of prevalent misconceptions and
controversies regarding TBDs are manifold. These
causes are likely related, in part, to the recent
emergence of these diseases, the variety of their
clinical manifestations, and the near ubiquitous
presence of ticks throughout suburban communities
in the northeastern United States.9,39 Both massmedia reporting and social networking contribute
to disparate information on these diseases. The
degree to which this leads to use of unproven
treatment strategies deserves study.43,45,46 Further
studies would assess the volume of social media,
content of news and social media, and the use of
unorthodox treatments for TBDs.

CONCLUSIONS
Lessening both the actual risk and perceived risks
associated with tick-borne infections represents an
ongoing challenge that needs continued attention
and effort. As the risk of acquiring TBDs varies
regionally, continued epidemiologic research
directed toward Maine communities may provide the
most accurate data on which to base local initiatives
for disease prevention. The recognition of new
TBDs and the changing landscape of disease risks
with ecological and human dynamics highlight the
importance of continuing the scientific and clinical
study of these different agents.2,6 Well-supported
information on the risks and consequences of
TBD, and their most effective clinical management,
optimally informs wise decisions in clinical and
5
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public health.26 Continued work to enhance disease
prevention may include efforts directed at different
scales, from individuals to regional or community
approaches. For example, new strategies for
integrated tick management may lower risk in
residential areas. Also, vaccine trials currently
underway may lead to new options for individual
protection. To impact the burden of TBDs, however,
these efforts must consider the role of interpersonal
communication and of social and mass media in
driving community perceptions and responses to the
emergence of TBDs.26,47 Realization of the benefits
of these scientific advances will require effective
strategies for public and professional education that
are based upon peer-reviewed scientific evidence.
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